Griffin Barbula
About Griffin Barbula
Griffin Barbula serves as the Executive Director of Analytical Chemistry and Operations at Erasca, Inc., a position he has held since 2023. He has extensive experience in analytical chemistry and regulatory submissions, having worked in various roles within the pharmaceutical industry for over a decade.
Work at Erasca
Griffin Barbula serves as the Executive Director of Analytical Chemistry and Operations at Erasca, Inc., a position he has held since 2023. In this role, he oversees analytical chemistry functions and operations, contributing to the company's mission in drug development. Prior to this, he worked as the Senior Director of Analytical Chemistry and Operations at Erasca from 2021 to 2023, where he played a key role in advancing the analytical capabilities of the organization.
Education and Expertise
Griffin Barbula earned a Bachelor of Arts in Chemistry and Biochemistry from the University of Colorado Boulder, studying from 2002 to 2005. He furthered his education at Stanford University, where he completed a PhD in Biophysical Chemistry from 2005 to 2010. His academic background provides a strong foundation for his expertise in analytical chemistry and operations within the pharmaceutical industry.
Background in Pharmaceutical Industry
Griffin Barbula has extensive experience in the pharmaceutical industry, having worked at Gilead Sciences in various roles from 2011 to 2018. His positions included Research Scientist I, Research Scientist II, and Senior Research Scientist. He also held leadership roles at Myovant Sciences, serving as Head of Technical Operations and Director of Analytical Chemistry. His experience encompasses leading analytical teams and supporting clinical development of combination products.
Achievements in Drug Development
Griffin Barbula has been involved in over 10 New Drug Applications (NDAs), where he served as the analytical lead for four applications and as the CMC lead for one. His contributions extend to Marketing Authorization Applications (MAA) and global regulatory submissions, showcasing his capability in navigating complex regulatory environments and supporting successful drug development initiatives.
Leadership in Analytical Chemistry
Griffin Barbula possesses broad experience in leading analytical chemistry teams. His leadership has been pivotal in supporting the clinical development of combination products that include up to four active ingredients. This experience highlights his ability to manage complex projects and ensure compliance with regulatory standards in the pharmaceutical sector.